2Calabrese LH. Molecular differences in anticytokine therapies.Clin Exp Rheumatol,2003,21:241-248.
3Feldmann M,Brennan FM,Maini RN. Role of cytokines in rheumatoid arthritis.Annu Rev Immunol,1996,14:397-440.
4Butler DM,Maini RN,Feldmann M,et al.Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures:comparison of monoclonal anti TNF-alpha antibody with the interleukin-1 receptor antagonist. Eur Cytokine Netw,1995,6:225-230.
5Braun J,Sieper J.The sacroiliac joint in the spondyloarthropathies.Curr Opin Rheumatol,1996,8:275-297.
6Sandborn WJ,Hanauer SB.Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents,pharmacology,clinical results and safety.Inflamm Bowel Dis,1999,5:119-133.
7Brandt J,Haibel H,Comely D,et al.Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab.Arthritis Rheum,2000,43:1346-1352.
8Brandt J,Haibel H,Sieper J,et al.Infliximab treatment of severe ankylosing spondylitis:one-year followup.Arthritis Rheum,2001,44:2936-2937.
9Allali F,Roux C,Kolta S,et al.Infliximab in the treatment of spondyloarthropathy, bone mineral density effect. Arthritis Rheum,2001,44:S89.
10Braun J,Brandt J,Listing J,et al.Treatment of active ankylosings with infliximab:a randomized controlled multicentre trial.Lancet,2002,359:1187-1193.
二级参考文献8
1Huang F, Gu J, Zhao W, et al. One-year open-hbel trial of thalidomide in ankylosing spondylitis. Arthritis Rheum (Arthritis Care Res), 2002,47: 249-254.
2Davis J, Huang F, Maksymowych WP. New therapies for ankylosing spondylitis: etanercept, thalidomide and pamidronate. Rheum Dis Clin North Am, 2003,29 : 501-517.
3Huang F, Wei J, Breban M. Thalidomide in ankylosing spondylitis.Clin Exp Rheumatol, 2002,20: S158-161.
4Huang F, Gu J, Zhao W, et al. Therapeutic effect and molecular targets of thalidomide in refractory ankylosing spondylitis. Arthritis Rheum,2001,44 : S275.
5Gorman J, Sack K, Davis J. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor α. N Engl J Med, 2002,346:1349-1356.
6Braun J, Brandt J, Listing J, et al. Treatment of active ankylosing spondylitis with infliximab: a randomized controlled multicentre trial. Lancet, 2002,359:1187.
7Antoni C,Bmun J. Side effects of anti-TNF therapy: current knowledge. Clin Exp Rheumatol, 2002,20: S152-157.
